Vbi Vaccines Stock Price on May 20, 2024
VBIV Stock | USD 0.56 0.01 1.75% |
Below is the normalized historical share price chart for VBI Vaccines extending back to August 26, 1985. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VBI Vaccines stands at 0.56, as last reported on the 29th of April, with the highest price reaching 0.59 and the lowest price hitting 0.53 during the day.
If you're considering investing in VBI Stock, it is important to understand the factors that can impact its price. VBI Vaccines owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0079, which indicates the company had a -0.0079% return per unit of volatility over the last 3 months. VBI Vaccines exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VBI Vaccines' Downside Deviation of 7.74, risk adjusted performance of 0.0205, and Market Risk Adjusted Performance of 0.2323 to confirm the risk estimate we provide.
At this time, VBI Vaccines' Common Stock Shares Outstanding is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 112.8 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 73.5 M in 2024. . Price To Sales Ratio is likely to drop to 1.00 in 2024. Price Earnings Ratio is likely to drop to -0.1 in 2024. VBI Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of August 1995 | 200 Day MA 0.7676 | 50 Day MA 0.6088 | Beta 1.917 |
VBI |
Sharpe Ratio = -0.0079
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | VBIV |
Estimated Market Risk
6.72 actual daily | 59 59% of assets are less volatile |
Expected Return
-0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VBI Vaccines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VBI Vaccines by adding VBI Vaccines to a well-diversified portfolio.
Price Book 0.8206 | Enterprise Value Ebitda (0.32) | Price Sales 2.0214 | Shares Float 26.6 M | Wall Street Target Price 5 |
VBI Vaccines Valuation on May 20, 2024
It is possible to determine the worth of VBI Vaccines on a given historical date. On May 20, 2024 VBI was worth 0.57 at the beginning of the trading date compared to the closed value of 0.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of VBI Vaccines stock. Still, in general, we apply an absolute valuation method to find VBI Vaccines' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of VBI Vaccines where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against VBI Vaccines' related companies.
Open | High | Low | Close | Volume | |
0.59 | 0.60 | 0.56 | 0.57 | 187,618 | |
04/29/2024 | 0.57 | 0.59 | 0.53 | 0.56 | 491,557 |
Backtest VBI Vaccines | | | VBI Vaccines History | | | VBI Vaccines Valuation | Previous |
VBI Vaccines Trading Date Momentum on May 20, 2024
On April 29 2024 VBI Vaccines was traded for 0.56 at the closing time. The top price for the day was 0.59 and the lowest listed price was 0.53 . The trading volume for the day was 491.6 K. The trading history from April 29, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.79% . |
VBI Vaccines Fundamentals Correlations and Trends
By evaluating VBI Vaccines' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among VBI Vaccines' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. VBI financial account trend analysis is a perfect complement when working with valuation or volatility modules.About VBI Vaccines Stock history
VBI Vaccines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VBI is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VBI Vaccines will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VBI Vaccines stock prices may prove useful in developing a viable investing in VBI Vaccines
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 15.6 M | 16.4 M | |
Net Loss | -102 M | -96.9 M |
VBI Vaccines Stock Technical Analysis
VBI Vaccines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
VBI Vaccines Period Price Range
Low | April 29, 2024
| High |
0.57 | 0.56 |
VBI Vaccines April 29, 2024 Market Strength
Market strength indicators help investors to evaluate how VBI Vaccines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading VBI Vaccines shares will generate the highest return on investment. By undertsting and applying VBI Vaccines stock market strength indicators, traders can identify VBI Vaccines entry and exit signals to maximize returns
VBI Vaccines Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for VBI Vaccines' price direction in advance. Along with the technical and fundamental analysis of VBI Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of VBI to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0205 | |||
Jensen Alpha | 0.0721 | |||
Total Risk Alpha | (0.74) | |||
Sortino Ratio | 0.0042 | |||
Treynor Ratio | 0.2223 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for VBI Stock analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.03) | Revenue Per Share 0.558 | Quarterly Revenue Growth 1.911 | Return On Assets (0.29) | Return On Equity (2.59) |
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.